ESMO 2022 | Challenges associated with understanding molecular determinants of immune checkpoint blockade

Benjamin Fairfax, BM BCh, MRCP, PhD, University of Oxford, Oxford, UK, discusses challenges associated with understanding molecular determinants of response to immune checkpoint blockade, including identifying the nature of antigens, as well as the scalability of these approaches. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.